The ICFSR 2024 Lifetime Achievement Award is awarded to Dr. Anne Newman for her pivotal contributions to the field of sarcopenia and frailty research related to our understanding of the life-course trajectories of muscle performance, physical functioning, and the onset of physical disability. Her work has provided a critical framework for our understanding of how the patho-physiological processes of aging influence the independence of older adults.
Keynotes speakers 2024
Anne Newman, MD, MPH University of Pittsburgh, PA, USA
“Health ABC to SOMMA: Leaning into aging biology to understand frailty and sarcopenia“
Anne B. Newman, MD, MPH is Distinguished Professor of Epidemiology and Professor of Medicine and Clinical and Translational Science in the School of Medicine. She is the Clinical Director of the Aging Institute of the University of Pittsburgh and UPMC and UPMC Chair of Geroscience. She has defined key metrics of physical functioning, frailty, and sarcopenia in epidemiology cohort studies, and has conducted clinical trials designed to prevent disability and extend health span.
She currently serves as a member of the National Institute on Aging Clinical Trials Advisory Panel (CTAP), and has completed service as a member of the Board of Scientific Counselors and the National Advisory Council on Aging.
She is a member of the American Federation for Aging Research(AFAR) National Scientific Advisory Council. Dr. Newman is also an Associate Editor of the Journal of Gerontology, Medical Sciences, after serving as the Editor-in Chief from 2016-2020.
Yves Rolland, MD, PhD Gerontopôle of Toulouse, University Toulouse Paul Sabatier, Toulouse (France)
“Current and investigational medications for the treatment of sarcopenia“
Yves Rolland, MD, PhD is a Professor of Internal Medicine and Geriatrics at the Gerontopôle of Toulouse (France) and has a postgraduate diploma in sports medicine. He is member of the CERPO Team, UMR1295 (INSERM) at the University Toulouse III Paul Sabatier (MAINTAIN - MAintain Functions and INTrinsec capacities with Aging: Preventive and Personalized INterventional Research). He is the Editor in chief of the Journal of Nursing Home Research (JNHR). He is the author of more than 400 articles indexed Pubmed including around 80 articles related to Nursing Home care.
Gustavo Duque, MD, PhD McGill University Health Centre, Montréal, Québec (Canada)
“Osteosarcopenia and the crossroad between muscle, bone and fat“
Professor Gustavo Duque, MD, Ph.D., FRACP, is a geriatrician and biomedical scientist with a research interest in the mechanisms, potential therapies, and biomarkers for age-related bone loss, osteoporosis, sarcopenia, osteosarcopenia, and frailty in older persons. Prof. Duque is Full Professor, Dr. Joseph Kaufmann Chair in Geriatric Medicine, Director - RUISSS McGill Centre of Excellence for Sustainable Health of Seniors/ Simone & Edouard Shouela (CEDurable), and Principal Investigator at the Bone, Muscle & Geroscience Group of the Research Institute of the McGill University Health Centre (MUHC). He is also the Editor-in-Chief of the Journal of Gerontology: Biological Sciences, one of the official journals of the Gerontological Society of America. His clinical trials unit conducts several trials testing the effect of pharmacological and non-pharmacological treatments for frailty and age-related musculoskeletal diseases. He is the author of more than 290 peer-reviewed articles and multiple book chapters and has edited five books in the aging and musculoskeletal fields (two on osteosarcopenia).
Luigi Ferrucci, MD, PhD National Institute on Aging/NIH, Baltimore, Maryland (USA)
“Translational Research on Mitochondria and Aging Frailty & Sarcopenia“
Dr. Luigi Ferrucci is a geriatrician and an epidemiologist who conducts research on the causal pathways leading to progressive physical and cognitive decline in older persons. He has made major contributions in the design of many epidemiological studies conducted in the U.S. and in Europe. Dr. Ferrucci received a Medical Degree and Board Certification in 1980, Board Certification in Geriatrics in 1982 and Ph.D. in Biology and Pathophysiology of Aging in 1998 at the University of Florence, Italy. Between 1985 and 2002 he was Chief of Geriatric Rehabilitation at the Department of Geriatric Medicine and Director of the Laboratory of Clinical Epidemiology at the Italian National Institute of Aging. In September 2002, he became the Chief of the Longitudinal Studies Section at NIA. From 2002 to 2014 he was the Director of the Baltimore Longitudinal Study on Aging. Dr. Ferrucci is currently the Scientific Director of NIA, since May 2011.
ICFSR24 Program highlights
- • Patient-reported outcomes in frailty and sarcopenia
- • Current and investigational medications for the treatment of sarcopenia
- • Osteosarcopenia and the crossroad between muscle, bone and fat
- • Translational Research on Mitochondria and Aging Frailty & Sarcopenia
- • Icope / integrated Care for older persons and maintaining intrinsic capacities for healthy longevity
- • Diversity and Equity in Frailty and Sarcopenia
- • Aging and homelessness: what challenges lie ahead?
- • Clinical and drug trials in frailty and sarcopenia
Abstracts ICFSR 2023
Abstracts ICFSR 2022